Seed · AI & Machine Learning · London, United Kingdom · Founded 2016 · 20–30 employees
ThinkSono has developed the world's first real-time AI-powered ultrasound guidance system that enables non-ultrasound trained healthcare professionals to diagnose deep vein thrombosis (DVT) at the point of care in under 15 minutes. The company achieved Class IIb CE mark regulatory approval in Europe for its flagship ThinkSono Guidance system in 2024. The technology addresses a critical healthcare bottleneck where patients often wait hours or days for DVT diagnosis, with DVT being associated with up to 900,000 cases annually in the US and costing the healthcare system up to $10 billion yearly. ThinkSono has raised approximately £5 million total funding and has partnerships with major hospitals across Europe and strategic collaborations with NYU Langone Health and Temple Health for FDA approval preparation.
No open roles listed right now.